{"cik":1692830,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"SATSUMA PHARMACEUTICALS, INC.","units":{"USD":[{"end":"2022-03-31","val":244000,"accn":"0001564590-22-019290","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-10","frame":"CY2022Q1I"},{"end":"2022-06-30","val":199000,"accn":"0001564590-22-028770","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-09","frame":"CY2022Q2I"},{"end":"2022-09-30","val":154000,"accn":"0001564590-22-036617","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-03","frame":"CY2022Q3I"},{"end":"2022-12-31","val":108000,"accn":"0000950170-23-010338","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-28"},{"end":"2022-12-31","val":108000,"accn":"0000950170-23-021208","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-11","frame":"CY2022Q4I"},{"end":"2023-03-31","val":82000,"accn":"0000950170-23-021208","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-11","frame":"CY2023Q1I"}]}}